LepnA.00629.a
Acetyl-coenzyme A synthetase
CENTER ID:
LepnA.00629.a
ORGANISM:
Legionella pneumophila Philadelphia 1 / ATCC 33152 / DSM 7513
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
False
NIH RISK GROUP:
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
LepnA.00629.a.B1.GE41429
Full length(LepnA.00629.a)
info
1
627
LepnA.00629.a.B1.GE41429
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
LepnA.00629.a.B1.PW38314
Full length(LepnA.00629.a)
info
1
627
PW38314
Structures
7MMZ
DEPOSITED: 4/30/2021
DETERMINATION: XRay
CLONE: LepnA.00629.a.B1.GE41429
PROTEIN: LepnA.00629.a.B1.PW38314
Publications by SSGCID
Bacterial Structural Genomics Target Enabled by Recently Discovered Potent Fungal ACS Inhibitor
Abendroth J, Hagen TJ, Bolejack M, Esan TE, DeBouver ND, Krysan DJ
Acta Crystallogr F Struct Biol Commun - 2023
issue 79, pages 137-143
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MLPVHLKHPH LTATEEYLSE FWSEIAAQTI DWIQPWSITL QGGLHKGDVK WFQGGLLNVS ANCLDRHLPH KANQTAIIWE GDDENQNKTL TFAQLYSEVC KMSNVLKSLN VRRGDTVGIY LPMIPEAAIA MLACARIGAI HTVVFAGFSA HALQQRLIAS SCKCLITADA FQRGGKTIPL KKQADEASVD LNITKLVVKN SNAPTALNKN KEHWWHELKQ TVSDQCTPEP MNTEDPLFIL YTSGSTGQPK GVVHTTGGYL VQAAYTHQLI FACQDNEVFW CTADVGWITG HSYVVYGPLC NGITTLMFEG IPTWPDAARN WRIIDKHQVN VFYTAPTAIR SLMRAGDQWL NSSSRSSLRL LGSVGEPINP EAWNWYHQKV GQGKCPIVDT WWQTETGAIM ISPRASDEVI KPGSARKPIP GIVPLLLNEQ GHEINGAGEG LLAIKYPWPS MARTIAGDHQ RYCNTYLSNG YYITGDGAKR DEDGDYWITG RIDDVLNVSG HRLGTAEIES ALVSHPKVAE AGVVGIPHDL KGQAIFAYVI LKQGNKPDAE LQTELMERVK DQISAIAKPD VIQFANDLPK TRSGKIMRRI LRKIACKEVS HIDELGDLTT LANPQIVEEL MKNILKR
NT Sequence
ATGCTTCCCG TTCATCTAAA GCACCCTCAT TTAACAGCTA CAGAAGAATA TCTATCTGAA TTTTGGTCTG AAATTGCCGC ACAAACCATT GACTGGATAC AACCTTGGAG TATCACCCTG CAGGGAGGAT TACACAAAGG CGATGTGAAG TGGTTTCAAG GCGGCTTACT CAATGTTAGC GCTAATTGTC TGGATAGGCA TTTACCCCAT AAAGCAAATC AAACAGCCAT CATTTGGGAA GGTGATGATG AAAACCAAAA TAAAACCCTG ACTTTTGCGC AGCTTTATTC TGAAGTATGC AAAATGAGCA ATGTGTTAAA AAGCCTAAAT GTTCGCAGAG GGGATACGGT AGGCATTTAC CTACCCATGA TTCCTGAAGC GGCCATTGCC ATGCTGGCTT GTGCTCGTAT AGGAGCTATT CATACCGTTG TGTTTGCCGG GTTTTCGGCC CATGCATTGC AGCAGCGATT AATAGCCTCT TCCTGTAAAT GTTTAATCAC TGCGGATGCG TTTCAACGCG GTGGAAAAAC TATCCCTTTA AAGAAACAGG CTGACGAAGC CAGCGTGGAC TTAAATATCA CCAAGCTGGT TGTTAAAAAT TCAAATGCCC CAACGGCACT AAATAAGAAC AAAGAACATT GGTGGCATGA GCTAAAACAA ACCGTATCGG ATCAATGCAC GCCGGAACCA ATGAACACCG AAGATCCCCT GTTTATTCTC TATACTTCCG GAAGCACGGG ACAGCCGAAA GGAGTGGTAC ATACCACAGG CGGCTATTTA GTGCAGGCCG CTTATACGCA TCAACTGATA TTTGCTTGTC AGGATAATGA AGTATTTTGG TGTACTGCTG ATGTCGGTTG GATTACAGGG CATAGTTATG TCGTCTATGG CCCTCTCTGC AATGGCATTA CCACATTGAT GTTTGAAGGA ATACCCACGT GGCCTGACGC AGCAAGAAAC TGGCGCATCA TTGATAAGCA CCAAGTGAAT GTGTTCTACA CAGCTCCCAC AGCCATCCGC TCCCTGATGA GAGCTGGCGA TCAATGGCTA AACTCAAGCT CAAGAAGTTC TCTTCGTTTA CTGGGTTCAG TGGGTGAGCC AATTAACCCG GAAGCATGGA ATTGGTATCA CCAAAAAGTT GGACAAGGGA AATGCCCGAT AGTGGATACA TGGTGGCAAA CTGAAACCGG AGCTATTATG ATTAGTCCCA GAGCCAGTGA TGAAGTGATC AAACCAGGCT CTGCTCGTAA ACCTATTCCG GGGATCGTAC CACTCCTGTT AAATGAGCAA GGACATGAAA TTAATGGCGC TGGAGAAGGC CTTTTGGCTA TCAAATACCC ATGGCCTTCT ATGGCAAGAA CCATTGCAGG AGATCACCAA AGATACTGTA ACACTTATTT ATCCAACGGC TATTACATCA CTGGTGATGG AGCCAAACGA GATGAAGATG GAGATTATTG GATTACAGGC CGAATTGATG ACGTACTTAA CGTTTCCGGC CATCGATTGG GTACTGCTGA AATTGAATCA GCATTGGTCA GCCATCCTAA GGTTGCTGAA GCTGGCGTTG TAGGTATTCC TCATGATTTA AAAGGTCAAG CAATATTTGC CTATGTCATT CTGAAGCAGG GAAATAAGCC TGATGCCGAG CTCCAAACTG AATTGATGGA GCGAGTCAAA GATCAAATCA GTGCTATCGC CAAACCAGAT GTCATTCAGT TTGCAAATGA TTTGCCGAAA ACCCGTTCAG GTAAAATTAT GCGCCGAATA CTAAGAAAAA TTGCTTGTAA AGAAGTGTCG CACATTGATG AGCTGGGTGA TTTAACAACT CTTGCTAACC CTCAGATCGT TGAGGAACTC ATGAAAAATA TTTTGAAGCG G
Details for LepnA.00629.a.B1.GE41429
HARVESTED ON:
4/5/2017
SEQUENCED ON:
4/27/2017
EXPECTED MW:
71kDa
OBSERVED MW:
71kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for LepnA.00629.a.B1.PW38314
PURIFICATION DATe:
7/17/2017
CONCENTRATION:
33.45mg/ml
OBSERVED MW:
69kDa
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
2
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable